Searching journal content for thyroid cancer (as phrase) in full text.

Displaying results 1-10 of 431
For checked items
  1. Review:
    • Maria Domenica Castellone and
    • Rosa Marina Melillo
    RET-mediated modulation of tumour microenvironment and immune response in MEN2 Endocr Relat Cancer ERC-17-0303, doi:10.1530/ERC-17-0303 first published on 20 September 2017
    ...gene expression, that can be 128 translated in differences in tumor microenvironment, and ultimately in disease severity in 129 MTC (Engelmann, et al. 2009). 130 131 Page 6 of 38 7 3. The role of microenvironment in thyroid cancer: FTC vs MTC 132 Human tumors must not be considered as simple masses ~~~
  2. Review:
    • Jolanta Krajewska,
    • Ewa Chmielik,
    • and Barbara Jarząb
    Dynamic risk stratification in the follow-up of thyroid cancer: what is still to be discovered in 2017? Endocr Relat Cancer 24 (11) R387-R402, doi:10.1530/ERC-17-0270 first published on 18 August 2017
    ...the overtreatment of low-risk and on the other hand the undertreatment of high-risk patients. The question how to properly assess the risk of relapse has been discussed during recent years and resulted in a substantial change in our approach to risk stratification in differentiated thyroid cancer, proposed ~~~
  3. Review:
    • Iuri Martin Goemann,
    • Mirian Romitti,
    • Erika L Souza Meyer,
    • Simone Magagnin Wajner,
    • and Ana Luiza Maia
    Role of thyroid hormones in the neoplastic process: an overview Endocr Relat Cancer 24 (11) R367-R385, doi:10.1530/ERC-17-0192
    .... The physical interaction of -catenin and TR was also demonstrated in a mouse model of thyroid cancer. T3 binding to TR weakened the -catenin/TR interaction, increasing the amount of -catenin available to be degraded via the proteasomal pathway (Guigonetal. 2008). -Catenin also interacts with TR1 ~~~
  4. Research:
    • Amruta Ashtekar,
    • Danielle Huk,
    • Alexa Magner,
    • Krista La Perle,
    • Xiaoli Zhang,
    • Jose Piruat,
    • Jose Lopez-Barneo,
    • Sissy Jhiang,
    • and Lawrence Kirschner
    Sdhd ablation promotes thyroid tumorigenesis by inducing a stem-like phenotype Endocr Relat Cancer ERC-17-0229, doi:10.1530/ERC-17-0229 first published on 19 September 2017
    ...-293-5264 24 25 Abstract: 169 26 Word count: 4749 27 Figures: 8 28 Keywords: Succinate dehydrogenase, Thyroid cancer, Stem cells, Metabolism, Mouse models 29 30 Page 1 of 37 Accepted Preprint first posted on 19 September 2017 as Manuscript ERC-17-0229 Copyright 2017 by the Society for Endocrinology. ABSTRACT ~~~
  5. Review:
    • Robert C. Mould,
    • Jacob P. van Vloten,
    • Amanda W. K. AuYeung,
    • Khalil Karimi,
    • and Byram W. Bridle
    Immune response in the thyroid cancer microenvironment: making immunotherapy a possible mission Endocr Relat Cancer ERC-17-0316, doi:10.1530/ERC-17-0316 first published on 14 September 2017
    ...Immune responses in the thyroid cancer microenvironment: making 1 immunotherapy a possible mission 2 3 Robert C. Mould, Jacob P. van Vloten, Amanda W. K. AuYeung, Khalil Karimi, Byram 4 W. Bridle* 5 Department of Pathobiology, University of Guelph, Guelph, Ontario, Canada 6 contributed equally 7 ~~~
  6. Thematic Review:
    • Rami Alrezk,
    • Fady Hannah-Shmouni,
    • and Constantine A Stratakis
    MEN4 and CDKN1B mutations: the latest of the MEN syndromes Endocr Relat Cancer 24 (10) T195-T208, doi:10.1530/ERC-17-0243 first published on 19 August 2017
    ...neoplasia-type 1. Science 276 404407. (doi:10.1126/ science.276.5311.404) Chiappetta G, De Marco C, Quintiero A, Califano D, Gherardi S, Malanga D, Scrima M, Montero-Conde C, Cito L, Monaco M, etal. 2007 Overexpression of the S-phase kinase-associated protein 2 in thyroid cancer. Endocrine-Related Cancer ~~~
  7. Review:
    • Lucas Leite Cunha,
    • Marjory Alana Marcello,
    • Vinicius Rocha-Santos,
    • and Laura Sterian Ward
    Immunotherapy against endocrine malignancies: immune checkpoint inhibitors lead the way Endocr Relat Cancer ERC-17-0222, doi:10.1530/ERC-17-0222 first published on 11 September 2017
    ...describe 27 the most essential concepts related to immune checkpoint inhibitors. We critically review the 28 literature on preclinical and clinical studies of the immune checkpoint inhibitors as a treatment 29 option for thyroid cancer, ovarian carcinoma, pancreatic adenocarcinoma, adrenocortical 30 ~~~
  8. Review:
    • Andreas Machens and
    • Henning Dralle
    Advances in risk-oriented surgery for multiple endocrine neoplasia type 2 Endocr Relat Cancer ERC-17-0202, doi:10.1530/ERC-17-0202 first published on 7 September 2017
    ...this uncommon disease, can be eliminated in our lifetime. 59 60 Page 2 of 33 1. Introduction (Word Count: 4117) 61 62 More than fifty years ago, the medical community witnessed the birth of a new hereditary endocrine 63 syndrome encompassing medullary thyroid cancer (MTC) and pheochromocytoma: Sipple syndrome ~~~
  9. Review:
    • Carole Guerin,
    • Pauline Romanet,
    • David Taieb,
    • Thierry Brue,
    • André Lacroix,
    • Frederic Sebag,
    • Anne Barlier,
    • and Frederic Castinetti
    Looking beyond the thyroid: advances in understanding of pheochromocytoma and hyperparathyroidism phenotypes in MEN2 and of non-MEN2 familial forms Endocr Relat Cancer ERC-17-0266, doi:10.1530/ERC-17-0266 first published on 5 September 2017
    ...and HRPT2 40 related HPTH are briefly described, with a focus on the most recent literature data, 41 and is compared with familial hypocalciuric hypalcemia. 42 43 44 Page 2 of 36 1. INTRODUCTION 45 The majority of the studies published on MEN2 focused on medullary thyroid cancer 46 (MTC), as it represents ~~~
  10. Research:
    • Maria Denaro,
    • Clara Ugolini,
    • Anello Marcello Poma,
    • Nicla Borrelli,
    • Gabriele Materazzi,
    • Paolo Piaggi,
    • Massimo Chiarugi,
    • Paolo Miccoli,
    • Paolo Vitti,
    • and Fulvio Basolo
    Differences in miRNA expression profiles between wild-type and mutated NIFTPs Endocr Relat Cancer 24 (10) 543-553, doi:10.1530/ERC-17-0167
    ...RNAs to carcinogenesis has been reported in recent years. miRNAs seem to be promising diagnostic and prognostic molecular markers for thyroid cancer, and the combination of miRNA expression and mutational status might improve cytological diagnosis. The aim of the present study was to evaluate the miRNA expression ~~~
For checked items

Search Results

Next 10 » New Search

Modify Results

Citation format:
Results / page:
Results order:

This search

  • Alert me when new articles matching this search are published
  • Download all citations on this page to my citation manager

New Articles: issue in progress

  1. November 2017, 24 (11)
  1. Current Issue
  1. Alert me to new issues of Endocrine-Related Cancer

Most